Definitions
Sorry, no definitions found. You may find more data at calando.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Calando.
Examples
-
Expanded Calando Scientific Advisory Board with the appointment of Timothy J. Triche, M.D., Ph.D. to guide future development of CALAA-01, contribute to partnering activities, initiate new clinical candidates, and expand the RONDEL delivery system.
unknown title 2011
-
We are pleased to announce that we have completed enrollment for the Calando Phase 1 trial, marking a significant milestone for us.
unknown title 2011
-
Heading into our fiscal fourth quarter, Arrowhead is focused on obtaining additional data for the Calando trial and partnering this program, as well advancing the Ablaris and Nanotope platforms.
unknown title 2011
-
In recent months our focus has been on advancing the platform technologies of Calando Pharmaceuticals and Ablaris Therapeutics into the clinic.
unknown title 2011
-
The increase in operating expenses was primarily due to increased outside lab services and contract services to support enrollment in Calando's clinical trial and increased costs related to foreign patent filings and attorney fees associated with Calando's intellectual property portfolio.
unknown title 2011
-
Of course the big catalyst relating to Calando would be some form of partnership with Big Pharma.
-
Turning to Calando, we continue to be enthusiastic about our prospects for Calando and it's Phase I trial with its lead RNAi Therapeutic candidate CALAA-01, new license proprietary RONDEL delivery system.
-
With Calando, we expect to continue to enroll new patients in our clinical trials and continue escalating the dose in search of a maximum tolerated dose.
-
Currently, Arrowhead is focused primarily on its two majority owned subsidiaries; Unidym, a leader in carbon nanotube technology for electronic applications, and Calando, at the forefront of clinical application of RNAi delivery technology.
-
The Phase I trial-sponsored by Calando Pharmaceuticals-is proceeding at START and UCLA's Jonsson Comprehensive Cancer Center, and the clinical results of the trial will be presented at a later time.
Nano Tech Wire 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.